Terms: = Prostate cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Prognosis
3 results:
1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
2. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort.
Bevilacqua V; Chan MK; Chen Y; Armbruster D; Schodin B; Adeli K
Clin Chem; 2014 Dec; 60(12):1532-42. PubMed ID: 25261558
[TBL] [Abstract] [Full Text] [Related]
3. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
Köbel M; Kalloger SE; Boyd N; McKinney S; Mehl E; Palmer C; Leung S; Bowen NJ; Ionescu DN; Rajput A; Prentice LM; Miller D; Santos J; Swenerton K; Gilks CB; Huntsman D
PLoS Med; 2008 Dec; 5(12):e232. PubMed ID: 19053170
[TBL] [Abstract] [Full Text] [Related]
